Drug and pharmaceutical recalls
346 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 8 of 12- Sagent Busulfan Injection recalled for impurity specifications failure
Sagent Pharmaceuticals is recalling two lots of Busulfan Injection due to failed impurities and degradation specifications. The affected lots are 656412 (expiring 08/31/2026) and 659646 (expiring 03/31/2027). This is a prescription medication used in cancer treatment.
ModerateFDAMay 27, 2026Sagent Pharmaceuticals
- Safecor Health atomoxetine capsules mislabeled with wrong strength
Safecor Health distributed atomoxetine 25 mg capsules that were labeled as 10 mg capsules. This labeling error affects one lot distributed in Texas. The mislabeling could result in patients taking a higher dose than prescribed.
ModerateFDAMay 27, 2026Safecor Health
- Amerisource Primidone tablets recalled for cross-contamination
Primidone tablets distributed by American Health Packaging were found to contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, due to cross-contamination during manufacturing. The affected lot (1027583, expiring 09/30/2027) contains approximately 63,500 tablets distributed nationwide. No injuries have been reported.
ModerateFDAMay 27, 2026Amerisource2 products
- Golden State Medical Supply primidone tablets recalled for contamination
Golden State Medical Supply is recalling Primidone 50 mg tablets because the active ingredient was contaminated with trace amounts of Acemetacin, a different medication. This contamination occurred during manufacturing. The affected bottles are identified by specific lot numbers with expiration dates in 2028.
ModerateFDAMay 27, 2026Golden State Medical Supply2 products
- Lannett Primidone tablets recalled for API contamination
Lannett Company's Primidone Tablets 250mg were contaminated during manufacturing with trace amounts of Acemetacin, a different active pharmaceutical ingredient. The contamination affected specific lot numbers distributed nationwide. No injuries have been reported.
ModerateFDAMay 27, 2026Lannett
- Ascend metoprolol succinate tablets recalled for failed dissolution
Ascend Laboratories is recalling one lot of metoprolol succinate extended-release 25 mg tablets because they failed to meet dissolution specifications. This means the tablets may not break down and release the medication properly in the body. The affected lot was distributed nationwide.
ModerateFDAMay 20, 2026Ascend Laboratories
- Endo USA buprenorphine injection recalled for particulate matter
Endo USA is recalling certain batches of buprenorphine hydrochloride 0.3 mg/mL injection due to the presence of particulate matter identified as buprenorphine free base in the vials. The affected lots are 84132 (expiration 02/28/2027) and 87693 (expiration 03/31/2027). No injuries have been reported.
ModerateFDAMay 20, 2026Endo USA
- Oasis Tears PF eye drops recalled for lack of sterility assurance
Oasis Medical is recalling specific lots of Oasis Tears PF preservative-free eye drops because the FDA found concerns about sterility assurance during an inspection. No injuries have been reported, but the company is recalling the product out of caution.
ModerateFDAMay 20, 2026Oasis Medical
Sun Pharma doxorubicin injection recalled for glass particlesSun Pharmaceutical is recalling one batch of Aisling doxorubicin hydrochloride liposome injection (a cancer medication) because glass particles were found in some vials during manufacturing. Glass particles in injectable medications can cause local tissue damage, blood vessel blockage, or blood clots if injected into the bloodstream. No patient injuries have been reported so far.
SeriousFDAMay 13, 2026
MG217 eczema cream recalled for Staphylococcus aureus contaminationPharmacal recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream (6oz tube, lot 1024088) because it was found to contain Staphylococcus aureus bacteria. The contaminated product could cause infections ranging from localized skin infections to serious conditions like sepsis, especially in people with weakened immune systems or compromised skin. No illnesses have been reported so far.
ModerateFDAMay 8, 2026Pharmacal
- Teva Claravis isotretinoin capsules recalled for impurity levels
Teva Pharmaceuticals is recalling specific lots of Claravis (isotretinoin) 10 mg capsules because they contain higher-than-allowed levels of tretinoin, a related chemical impurity. The affected lots are 100067507 and 100067508, which expire on July 31, 2026. No injuries have been reported so far.
ModerateFDAApr 29, 2026Teva
Stop using B. Braun Lactated Ringer's InjectionB. Braun Medical is recalling two lots of Lactated Ringer's Injection (1L, product code E7500) because the solution contains unwanted particles, including cellulose and stearates. If these particles enter a patient's bloodstream during use, they could cause serious complications including blood clots, tissue damage, or organ failure.
SeriousFDAApr 28, 2026B. Braun
- Stop using Avantor Magnesium Chloride
Avantor Performance Materials has recalled Magnesium Chloride, 6-Hydrate Crystal (500G bottles, Lot 23G3161005, expiration 9/21/2027) because the product does not meet strength specifications. This bulk pharmaceutical ingredient may be less potent than labeled.
ModerateFDAApr 22, 2026Avantor
- Skin Script blemish spot treatment recalled for failed stability
Island Kinetics, Inc. (d.b.a. CoValence Laboratories) is recalling specific lots of Skin Script Blemish Spot Treatment because the product failed stability testing. This means the product may not maintain its intended strength or safety over time. No injuries have been reported.
ModerateFDAApr 22, 2026CoValence Laboratories
- Major Pharmaceuticals memantine capsules recalled for failed dissolution
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
ModerateFDAApr 22, 2026The Harvard Drug
- Stop using recalled epinephrine injection
International Medication Systems Ltd. is recalling one lot of epinephrine injection due to concerns that the sterility of the product cannot be assured. The affected lot (EA038A5, expiring 08/2026) was distributed nationwide. No injuries have been reported.
ModerateFDAApr 22, 2026International Medication Systems
- Remedy, Skin Rehab and Essential gels recalled for low potency
CoValence Laboratories is recalling three hydrocortisone 1% skin gels because they may contain less hydrocortisone than the label states. The recall covers Remedy Gel (distributed by glo Skin Beauty), and Skin Rehab Calming Skin Gel and Essential Calming Skin Gel (both distributed by A.C.E. Inc.). No injuries have been reported.
ModerateFDAApr 22, 2026CoValence Laboratories3 products
- Stop using Nephron SC albuterol solution
Nephron SC is recalling albuterol sulfate inhalation solution (0.5%, 30x5 mL vials, Lot AB6001, expiring 1/15/2027) because the labels are illegible and cannot be read clearly. This makes it difficult to verify the correct dose and medication details. The recall affects 146,280 vials distributed nationwide.
ModerateFDAApr 22, 2026Nephron
- Sun Pharmaceutical fluocinonide cream recalled for failed viscosity specifications
Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to a manufacturing defect. Testing found the cream's thickness was thicker than specifications allow, which could affect how the medication works on your skin.
ModerateFDAApr 22, 2026Sun Pharmaceutical3 products
- Stop using Payless Compounders semaglutide injections
Payless Compounders is recalling a compounded semaglutide injection due to lack of assurance of sterility. The affected product is a 0.5 mL vial from lot 01-27-2026@14S.5 distributed in Oregon. No injuries have been reported so far.
ModerateFDAApr 22, 2026Payless Compounders
- MGC, QC and more cough drops recalled over quality issues
Kang Zhongyuan is recalling 15 menthol cough drop products after an FDA inspection of the manufacturing facility on August 15, 2025 turned up observations that may affect product quality. The products are sold under the names exchange select, caring mill, Discount Drug Mart Food Market, MGC Health and QC Quality Choice, and are distributed nationwide. No injuries have been reported.
ModerateFDAApr 22, 2026Kang Zhongyuan15 products
- FarmHouse Fresh, HydroPeptide and SLMD acne treatments recalled for benzene
Owen Biosciences is recalling four benzoyl peroxide acne products over possible benzene contamination, a chemical linked to cancer with long-term exposure. The products are FHF Farmhouse Fresh Midnight Clearing Night Lotion, HydroPeptide Clear Alliance Serum, and two SLMD (Sandra Lee MD) acne products, distributed by Skin PS Brands. No injuries have been reported.
ModerateFDAApr 22, 2026Owen Biosciences4 products
- Cipla cinacalcet tablets recalled for N-nitroso impurity above limit
Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain higher-than-acceptable levels of a chemical impurity called N-Nitroso Cinacalcet. The affected tablets were distributed nationwide. This is a manufacturing quality issue; no injuries have been reported.
ModerateFDAApr 22, 2026Cipla3 products
- Teva clonidine patches recalled for unapproved raw material
Teva Pharmaceuticals is recalling certain Clonidine Transdermal System patches (0.1 mg/day) because they were manufactured using an unapproved raw material that does not meet FDA standards. The affected patches were distributed in the U.S. The company and FDA are working to ensure the product is removed from use.
ModerateFDAApr 15, 2026Teva3 products
- Check GE Healthcare Omnipaque injection lot numbers
GE Healthcare has recalled specific lots of Omnipaque (iohexol) injection, a contrast dye used in medical imaging, because some vials may contain visible particles. This could affect the safety of the procedure if the contaminated solution is used.
ModerateFDAApr 15, 2026GE Healthcare2 products
- Teva isotretinoin capsules recalled for potency errors
Teva is recalling two strengths of isotretinoin capsules, 30 mg and 40 mg, because some capsules may be stronger or weaker than the labeled amount. The recall covers 10-count prescription packs distributed in Florida, Ohio, Puerto Rico and Mississippi, and no injuries have been reported.
ModerateFDAApr 15, 2026Teva2 products
- Xanax XR 3 mg tablets recalled for failed dissolution
Viatris is recalling one lot of Xanax XR (alprazolam) 3 mg extended-release tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This affects only lot #8177156 with an expiration date of 02/28/2027, distributed nationwide. No injuries have been reported.
ModerateFDAApr 15, 2026Viatris
- Preferred Pharmaceuticals eye drops recalled for lack of sterility assurance
Preferred Pharmaceuticals' Artificial Tears Lubricant Eye Drops in 0.5 oz bottles may not be sterile due to a manufacturing issue. The FDA is recalling specific lots because sterility cannot be assured. No injuries have been reported.
ModerateFDAApr 15, 2026Preferred Pharmaceuticals
- Fagron IV norepinephrine and vancomycin bags recalled for sterility concerns
Fagron Compounding Services is recalling five premixed IV bags in 0.9% sodium chloride: norepinephrine bitartrate (16 mg and 32 mg per 250 mL) and vancomycin (1 g, 1.25 g and 1.5 g per 250 mL). The bags were made by Fagron Sterile Services in Wichita, Kansas, and sold nationwide, and the company cannot assure they are sterile. A blue break-off part on the administration port could also detach. No injuries have been reported.
SeriousFDAApr 15, 2026Fagron Compounding Services5 products
- Fresenius Kabi IV saline and dextrose bags recalled over sterility
Fresenius Kabi is recalling 14 sodium chloride and dextrose IV fluid bags because the company cannot assure they are sterile. The products were sold under the Fresenius Kabi, BD and Fresenius Medical Care names and were distributed nationwide, to Alaska and to Puerto Rico. No injuries have been reported.
ModerateFDAApr 15, 2026Fresenius Kabi14 products